Warfarin and INR: Therapeutic Range and Dosing Guide
How clinicians keep warfarin therapy safe and effective.
Warfarin is one of the oldest oral anticoagulants still in widespread use. Unlike newer direct oral anticoagulants (DOACs), warfarin requires regular blood testing to measure the International Normalized Ratio (INR) and frequent dose adjustments.

What Is INR?
The INR is a standardized measure of how long it takes blood to clot. It corrects for differences in laboratory reagents. For people not on warfarin, the INR is typically around 1.0. For most warfarin indications, the target INR is between 2.0 and 3.0.
Therapeutic Ranges by Condition
| Condition | Target INR |
|---|---|
| Atrial fibrillation (non-valvular) | 2.0–3.0 |
| Deep vein thrombosis (DVT) / Pulmonary embolism (PE) | 2.0–3.0 |
| Mechanical heart valve (bi-leaflet aortic, low risk) | 2.0–3.0 |
| Mechanical mitral valve | 2.5–3.5 |
| Recurrent clots while in therapeutic range | 2.5–3.5 |
Factors That Raise INR
- Antibiotics (especially trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin)
- Amiodarone, statins, and some antifungals
- Acute illness, fever, or dehydration
- Heavy alcohol use or binge drinking
- High intake of vitamin K–rich foods (actually lowers INR)
When to Seek Help
Contact your clinician if your INR is unexpectedly high or low, if you notice bleeding (bruising, nosebleeds, blood in urine/stool), or if you miss more than one dose.
Use our warfarin dosing calculator for general guidance on INR-based adjustments.
Book a telemedicine consultation or lab review with Dr. Taimoor Asghar.